Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon
Clinical trial NCT03600714 · COMPLETED
Trial details
- NCT number
- NCT03600714
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-02-05
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.